Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:40:46 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:DERM - JOURNEY MEDICAL CORPORATION - https://ir.journeymedicalcorp.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DERM - Q0.16.96·8.660.18.3555.04228938.49  8.5323  8.339.5493  4.6716:10:04Dec 1015 min RT 2¢

Recent Trades - Last 10 of 893
Time ETExPriceChangeVolume
16:10:04Q8.35 1
16:10:04Q8.35 1
16:04:29Q8.35 1
16:02:15Q8.35 273
16:00:03Q8.35 12
16:00:01Q8.35 312
16:00:01Q8.35 100
16:00:01Q8.35 58
16:00:01Q8.35 10
16:00:01Q8.35 1

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-10 08:30U:DERMNews ReleaseJourney Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi(TM) (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
2025-11-12 16:01U:DERMNews ReleaseJourney Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
2025-11-05 08:30U:DERMNews ReleaseJourney Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
2025-10-24 08:30U:DERMNews ReleaseJourney Medical Corporation Reports Combined Emrosi(TM) (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
2025-10-08 08:31U:DERMNews ReleaseJourney Medical Corporation to Participate in October 2025 Investor Conferences
2025-09-03 08:31U:DERMNews ReleaseJourney Medical Corporation to Participate in September 2025 Investor Conferences
2025-08-18 08:30U:DERMNews ReleaseJourney Medical Corporation to Present at the Emerging Growth Conference
2025-08-12 16:01U:DERMNews ReleaseJourney Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
2025-08-07 08:30U:DERMNews ReleaseJourney Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
2025-08-05 16:01U:DERMNews ReleaseJourney Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
2025-07-14 08:30U:DERMNews ReleaseJourney Medical Corporation Announces Expanded Payer Coverage for Emrosi(TM)
2025-06-24 08:30U:DERMNews ReleaseJourney Medical to Join Russell 2000(TM) and Russell 3000(TM) Indexes
2025-06-20 08:31U:DERMNews ReleaseJourney Medical Corporation Announces Emrosi(TM) Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
2025-06-09 08:30U:DERMNews ReleaseJourney Medical Corporation Announces Emrosi(TM) Featured on "The Balancing Act" Airing on Lifetime TV
2025-05-15 16:05U:DERMNews ReleaseFortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-14 16:02U:DERMNews ReleaseJourney Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-07 16:01U:DERMNews ReleaseJourney Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
2025-04-01 16:01U:DERMNews ReleaseJourney Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
2025-03-26 16:01U:DERMNews ReleaseJourney Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
2025-03-24 08:30U:DERMNews ReleaseJourney Medical Corporation Launches Emrosi(TM) (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea